Taiwan’s commercial property transactions more than doubled to US$2.6 billion last quarter, making it the sixth largest market in the Asia-Pacific region, Real Capital Analytics Inc (RCA) said in a report on Tuesday.
The increase in the nation came while the region saw a 38 percent decline during the same period, the report added.
The sale of a hotel in Taipei for nearly US$1 billion contributed largely to the upturn, the analyst said, adding that real-estate transactions in the industrial sector were strong on the back of robust trading.
Taiwan also climbed ahead of Singapore on the leaderboard of most active markets in the region, it said, adding that the first nine months of the year saw sales of US$3.9 billion.
“The escalation of trade tensions between China and the US has resulted in another wave of investment into manufacturing facilities across Asia. Taiwan was no exception, as industrial investment spiked last quarter to US$1.3 billion, a record high for a single quarter,” RCA senior analyst for Asia Pacific Benjamin Chow said.
Taiwan’s strong performance stands in stark contrast to the overall showing in the region where sales of commercial property fell 38 percent between July and September as the COVID-19 pandemic slowed cross-border deals, RCA said.
Income-producing property sales dropped to US$26 billion, down from US$33 billion in the previous quarter and US$42.2 billion a year earlier, it said.
Industrial sector activity matched the level of last year, but all other key property types in the region declined, with hotel and retail sales seeing the sharpest drop, the firm said.
Transactions involving individual properties increased from the second quarter to US$23 billion, boosted by a small amount of high-value deals, while portfolio sales fell to levels last seen during the 2008 global financial crisis, it said.
Sales of development sites, with a majority taking place in China, grew from a year earlier, with deal volume totaling US$162 billion, an 18 percent year-on-year increase, RCA said.
“The COVID-19 pandemic will continue to hamper deal-making for cross-border investors as economic uncertainty in many markets puts many of them on hold,” RCA managing director for Asia Pacific David Green-Morgan said.
Markets with robust domestic demand — such as South Korea, Japan and China — are holding up better in the current environment, Green-Morgan said.
UNSTABLE? Downplaying geopolitical concerns, Mark Liu said that Taiwan can help usher in a bright, new era for the chip industry with its tech and manufacturing skills There are probably not many people who believe that Taiwan is unstable because of geopolitical factors, Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) chairman Mark Liu (劉德音) said yesterday in Taipei in response to comments by Intel’s top executive. Intel CEO Pat Gelsinger on Wednesday told the Fortune Brainstorm Tech summit in California that the US government should support a sustainable semiconductor supply chain in the US, in part because “Taiwan is not a stable place.” With China sending 27 military warplanes into Taiwan’s air defense identification zone on Sunday, Gelsinger asked: Does that “make you more comfortable or less if you’re now
‘OUT IN FRONT’: The new investment is part of MediaTek’s bid to expand revenue by 15 percent over the next three years from an estimated US$17 billion this year MediaTek Inc (聯發科) is to continue investing in the development of low-power technologies to maintain its leading position in the industry over the next 10 years, the Hsinchu-based chip designer said yesterday. This year, it would allocate US$3.3 billion to the research and development of technologies related to high-performance computing, low power and advanced chip packaging, MediaTek said. The investment is part of the chip designer’s efforts to enhance its technological capabilities and boost revenue. MediaTek aims to expand revenue by about 15 percent over the next three years from an estimated US$17 billion this year. “We are definitely out in front of
PharmaEssentia Corp (藥華醫藥) shares have jumped 80.56 percent since the company obtained a US polycythemia vera (PV) drug license for its new interferon drug Besremi (ropeginterferon alfa-2b-njft) on Nov. 12. Shares on Friday closed at NT$195 in Taipei trading, up from the stock’s closing price of NT$108 on Nov. 12. PV is a rare, chronic and life-threatening blood cancer linked to a stem cell mutation in the bone marrow that results in an overproduction of blood cells and places sufferers at risk of having a blood clot, stroke or heart attack. PharmaEssentia is preparing to make Besremi available in the US in the
The US$410 DeliSofter pot looks much like the rice cookers ubiquitous in Japanese households and it does prepare rice in 24 minutes. However, this invention of two Panasonic Corp engineers is designed to do more and help people with swallowing difficulties. The two women led the creation of a spin-off company, Gifmo Co, to sell the specialized steam cooker, which they say can turn fried chicken soft enough to be sliced with a potato chip. The machine works by first cutting into food with a series of blades and then subjecting it to extremely high pressure at a temperature of 120°C,